“We feel very fortunate to have speakers who are leaders in high-dimensional data analysis and clinical medicine from a wide range of disciplines together in San Diego to help us tackle the challenges of precision medicine,” says 2017 Clinical Research Conference co-chair Soumya Raychaudhuri, MD, PhD, Harvard Medical School.
In addition, participants will have a better understanding of the complexities and challenges in identifying the optimal drug for individual patients with rheumatic disease.
“The focus of this year’s CRC is timely, not just for rheumatology but for healthcare and research generally. Several characteristics of rheumatic diseases, particularly their heterogeneity, make them ideal candidates for a precision medicine approach to diagnosis and treatment. We hope ACR attendees will take advantage of this unique opportunity to hear from leaders in the field about opportunities for applying a precision medicine approach to rheumatic disease care and research,” says 2017 Clinical Research Conference co-chair Lindsey Criswell, MD, MPH, University of California-San Francisco.
Space is limited, and a separate registration is required, register now.
